Minerva Surgical, Inc. (UTRS) Tops Q2 EPS by 4c

Minerva Surgical, Inc. (NASDAQ: UTRS) reported Q2 EPS of ($0.05), $0.04 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $13.4 million versus the consensus estimate of $13.81 million.

For earnings history and earnings-related data on Minerva Surgical, Inc. (UTRS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79